Investigating a new drug that targets a specific serotonin receptor linked to various behaviors and conditions.
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
This study is exploring new ways to activate a specific brain receptor that helps with mood, thinking, and addiction, aiming to find better treatments for conditions like autism, sleep problems, and substance abuse.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Florida Agricultural and Mechanical Univ NIH-funded |
| Lab location | 1 site (Tallahassee, United States) |
| Project ID | NIH-11057613 on NIH RePORTER |
What this research studies
This research focuses on the 5-hydroxytryptamine 7 receptor (5-HT7R), which is involved in many important functions such as mood regulation, cognitive abilities, and addictive behaviors. The project aims to develop and test new compounds that selectively activate this receptor, potentially leading to better treatments for conditions like autism spectrum disorders, sleep issues, and substance abuse. By creating biased ligands that target specific signaling pathways, the research seeks to clarify the receptor's role in these conditions and improve therapeutic outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults over 21 who struggle with conditions related to mood, cognition, or substance abuse.
Not a fit: Patients with conditions unrelated to the 5-HT7 receptor or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for psychiatric disorders and substance abuse, improving the quality of life for many patients.
How similar studies have performed: Previous research has shown promise in targeting the 5-HT7 receptor, but this specific approach using biased ligands is relatively novel.
Where this research is happening
Tallahassee, United States
- Florida Agricultural and Mechanical Univ — Tallahassee, United States (Active)
Researchers
- Principal investigator: Ablordeppey, Seth Y — Florida Agricultural and Mechanical Univ
- Study coordinator: Ablordeppey, Seth Y
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.